Results 11 to 20 of about 20,877 (256)
Pityriasis rubra pilaris following administration of SARS‐CoV‐2 vaccine
Pityriasis rubra pilaris (PRP) is a rare, chronic, inflammatory dermatosis characterized by follicular, hyperkeratotic papules and palmoplantar keratoderma at any age. The exact etiology of the disease remains unknown, but it can be triggered by multiple
Shumpei Kondo +3 more
doaj +1 more source
Challenges in Diagnosis and Management of Cutaneous Adverse Drug Reaction
Adverse drug reactions commonly involve the skin and represent a significant proportion of all drug‐induced illnesses. Most of the times, adverse cutaneous reactions are not severe and only a few are fatal.
Manish Pradhan
doaj +3 more sources
Histopathology of drug eruptions-general criteria, common patterns, and differential diagnosis
Drug eruptions are among the most common inflammatory diseases of the skin and also among those biopsied most often. Yet, the value of histopathologic examination of drug eruptions has often been disputed.
Wolfgang Weyers, Dieter Metze
doaj +1 more source
Cetirizine-induced fixed drug eruption: a case report and review of literature
Cetirizine is a commonly used antihistamine in the management of itchy dermatoses, allergic reactions and cutaneous drug eruptions. However, it can rarely be the causative agent in cutaneous drug eruptions.
Sanjeewani Fonseka, Brabaharan Subhani
doaj +1 more source
A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
Drug-induced cutaneous eruptions are named among the most common side effects of many medications. Thus, cutaneous drug eruptions are a common cause of morbidity and mortality, especially in hospital settings.
Nisha Mistry +2 more
doaj +1 more source
Case Report: Nicolau syndrome due to etofenamate injection [version 1; referees: 2 approved]
Nicolau syndrome, also known as embolia cutis medicomentosa, is a rare complication characterized by tissue necrosis that occurs after injection of drugs.
Emin Ozlu +6 more
doaj +1 more source
Vemurafenib and cutaneous adverse events - report of five cases [PDF]
Vemurafenib is a selective inhibitor of V600E-mutant BRAF protein used to treat metastatic and unresectable melanoma. Clinical trials have shown increased overall survival and progression-free survival in patients treated with Vemurafenib.
Giselle de Barros Silva +5 more
doaj +1 more source
Olanzapine-induced skin eruptions
Adverse cutaneous reactions are known to occur with psychotropic medications, which may lead to poor drug compliance. As compared to other group of psychotropics, there is relatively scarce literature on olanzapine-induced skin eruptions.
Nishtha Chawla +2 more
doaj +1 more source
Drug eruption by antihistamine mistaken for chronic urticaria in a child [PDF]
Although rare, antihistamines can cause adverse effects, including drug-induced eruptions or anaphylaxis. A 4-year-old child visited the pediatric department of a hospital for skin eruptions after administration of antihistamines, (e.g., ucerax ...
Gun Moo Lee +5 more
doaj +1 more source
Retrospective analysis of drug eruptions in 89 cases
Objective To investigate the clinical features of drug eruptions and the most common causative drugs in inpatients in order to provide a reference for the diagnosis and the treatment of drug eruptions.
ZHANG Yali +5 more
doaj +1 more source

